Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma
β Scribed by Jean-Claude Bystryn; Ruth Oratz; Daniel Roses; Matthew Harris; Milagros Henn; Robert Lew
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 795 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A significant percentage of stage II melanoma patients (tumor thickness >1 mm) remain at risk of tumor recurrence after primary tumor excision. In this study, we used tumor antigenβpulsed dendritic cells as an adjuvant for immunization of these βhighβriskβ melanoma patients after resect
## BACKGROUND. Melanoma patients who carry the human leukocyte antigen (HLA) Class I1 allele DQLll\*0301 have an increased frequency of metastases at presentation compared with those lacking HLA-DQB1\*0301. This study was designed to determine whether HLA-DQBI\*0301 is associated with an increased